U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H27N3O5S
Molecular Weight 445.532
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLISENTIDE

SMILES

COC1=C(C=CC=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCC3

InChI

InChIKey=NSJYMFYVNWVGON-UHFFFAOYSA-N
InChI=1S/C22H27N3O5S/c1-30-20-9-5-4-8-19(20)21(26)23-15-14-16-10-12-18(13-11-16)31(28,29)25-22(27)24-17-6-2-3-7-17/h4-5,8-13,17H,2-3,6-7,14-15H2,1H3,(H,23,26)(H2,24,25,27)

HIDE SMILES / InChI
Glisentide (glypentide) is a hypoglycemic agent and part of the second-generation sulfonamide derivatives. Glisentide is used as an oral medication to control blood sugar levels in patients with diabetes mellitus type 2. Glisentide is patented by Uriach as Staticum®. This compound appears to decrease total lipid and cholesterol levels. Results of glisentide administration in humans showed that this oral hypoglycemic drug was well tolerated and had a similar, and in many instances superior, activity to other similar drugs such as glybenclamide and glipizide.

Approval Year

Name Type Language
STATICUM
Preferred Name English
GLISENTIDE
INN   MART.   WHO-DD  
INN  
Official Name English
Su661
Code English
1-CYCLOPENTYL-3-((P-(2-(O-ANISAMIDO)ETHYL)PHENYL)SULFONYL)UREA
Common Name English
UR661
Code English
glisentide [INN]
Common Name English
Su-661
Code English
UR-661
Code English
GLIPENTIDE
Common Name English
Glisentide [WHO-DD]
Common Name English
GLISENTIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C97936
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
Code System Code Type Description
INN
3163
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
NCI_THESAURUS
C72799
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
DRUG CENTRAL
1303
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
PUBCHEM
65779
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
FDA UNII
392TQL1E2Z
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
EVMPD
SUB07930MIG
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
CAS
32797-92-5
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
EPA CompTox
DTXSID10186465
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
ECHA (EC/EINECS)
251-226-3
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
SMS_ID
100000084223
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105089
Created by admin on Mon Mar 31 17:58:58 GMT 2025 , Edited by admin on Mon Mar 31 17:58:58 GMT 2025
PRIMARY